World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
8350
World Ranking
4529
National Ranking
298

Vera Rebmann publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Vera Rebmann sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 150 publications — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Vera Rebmann D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Vera Rebmann sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Vera Rebmann is affiliated with Essen University Hospital in Germany and has contributed extensively to research in Medicine and Immunology and Microbiology. Their work spans several subfields including Immunology, Oncology, Reproductive Medicine, Infectious Diseases, and Hematology.

Their primary research topics include:

  • Reproductive System and Pregnancy
  • Immune Cell Function and Interaction
  • Endometriosis Research and Treatment
  • Hematopoietic Stem Cell Transplantation
  • Cancer Immunotherapy and Biomarkers
  • CAR-T cell therapy research
  • Extracellular vesicles in disease

Recent papers by Vera Rebmann cover various aspects of immunology and oncology, such as:

  • "Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma", 2020, Annals of Oncology
  • "Soluble HLA-G and HLA-G Bearing Extracellular Vesicles Affect ILT-2 Positive and ILT-2 Negative CD8 T Cells Complementary", 2020, Frontiers in Immunology
  • "Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy", 2020, Frontiers in Immunology
  • "Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapse", 2022, Journal of Cancer Research and Clinical Oncology
  • "Expression analysis of immune-regulatory molecules HLA-G, HLA-E and IDO in endometrial cancer", 2020, Human Immunology

Vera Rebmann frequently publishes in the following venues:

  • Frontiers in Immunology
  • Human Immunology
  • E-Posters
  • Annals of Oncology
  • Journal of Cancer Research and Clinical Oncology

The scientist collaborates regularly with coauthors including:

  • Peter A. Horn (13 collaborations)
  • Hana Rohn (10 collaborations)
  • Sabine Schramm (6 collaborations)
  • Esther Schwich (5 collaborations)
  • Inès Zidi (5 collaborations)

In addition to journal articles, Vera Rebmann has contributed to books published by Frontiers Media, including the 2024 publication "Current Progress in Genomic and Genetic Research on Human Viral Diseases."

Best Publications

  • MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

    Kordelas L;Rebmann;Ludwig Ak;Radtke S

  • Precipitation with polyethylene glycol followed by washing and pelleting by ultracentrifugation enriches extracellular vesicles from tissue culture supernatants in small and large scales.

    Anna-Kristin Ludwig;Anna-Kristin Ludwig;Kyra De Miroschedji;Thorsten R. Doeppner;Thorsten R. Doeppner;Verena Börger

  • HLA-DR Expression and Soluble HLA-DR Levels in Septic Patients After Trauma

    Markus Ditschkowski;Ernst Kreuzfelder;Vera Rebmann;Stanislav Ferencik

  • HLA-G is a potential tumor marker in malignant ascites.

    Gad Singer;Vera Rebmann;Yu Chi Chen;Hsu Tai Liu

  • Association of soluble HLA-G plasma levels with HLA-G alleles.

    V. Rebmann;K. Van Der Ven;M. Päßler;K. Pfeiffer

  • The immunosuppressive molecule HLA-G and its clinical implications.

    Alvaro González;Vera Rebmann;Joel LeMaoult;Peter A Horn

  • Detection of soluble HLA‐G molecules in plasma and amniotic fluid

    V Rebmann;K Pfeiffer;M Pässler;S Ferrone

  • HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

    Holger Nückel;Vera Rebmann;Jan Dürig;Ulrich Dührsen

  • Soluble human leukocyte antigen–G serum level is elevated in melanoma patients and is further increased by interferon-α immunotherapy

    Selma Ugurel;Vera Rebmann;Soldano Ferrone M.D.;Wolfgang Tilgen

  • Polymorphic Sites at the 3’ Untranslated Region of the HLA-G Gene Are Associated with Differential hla-g Soluble Levels in the Brazilian and French Population

    Gustavo Martelli-Palomino;Gustavo Martelli-Palomino;Gustavo Martelli-Palomino;Joao A. Pancotto;Joao A. Pancotto;Joao A. Pancotto;Yara C. Muniz;Yara C. Muniz;Celso T. Mendes-Junior

  • Functional Role of Human Leukocyte Antigen-G Up-Regulation in Renal Cell Carcinoma

    Jürgen Bukur;Vera Rebmann;Hans Grosse-Wilde;Hans Luboldt

  • Secretion of sHLA-G molecules in malignancies

    Vera Rebmann;Jens Regel;Dietmar Stolke;Hans Grosse-Wilde

  • Secretion of pro-apoptotic intron 4-retaining soluble HLA-G1 by human villous trophoblast.

    Corinne Solier;Maryse Aguerre-Girr;Françoise Lenfant;Agnès Campan

  • HLA-G 3' untranslated region variants +3187G/G, +3196G/G and +3035T define diametrical clinical status and disease outcome in epithelial ovarian cancer.

    Esther Schwich;Vera Rebmann;Rafael Tomoya Michita;Rafael Tomoya Michita;Hana Rohn

  • HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy

    Vera Rebmann;Fabiola da Silva Nardi;Bettina Wagner;Peter A. Horn

  • Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy.

    Lisa König;Sabine Kasimir-Bauer;Ann-Kathrin Bittner;Oliver Hoffmann

  • The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells

    Roberta Rizzo;Martine Vercammen;Hilde van de Velde;Peter A. Horn

  • The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia

    H Nückel;M Switala;L Sellmann;P A Horn

  • Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004

    Vera Rebmann;Joël LeMaoult;Nathalie Rouas-Freiss;Edgardo D. Carosella

  • Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma.

    Stephan N Wagner;Vera Rebmann;Christoph P Willers;Hans Grosse-Wilde

  • Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.

    Vera Rebmann;Philipp Schütt;Dieter Brandhorst;Bertram Opalka

  • Soluble HLA levels in early pregnancy after in vitro fertilization.

    Kerstin A Pfeiffer;Vera Rebmann;Monika Pässler;Kathrin van der Ven

  • Detection of HLA-G5 secreting cells.

    Vera Rebmann;Annika Busemann;Monica Lindemann;Hans Grosse-Wilde

  • HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia Short title: HLA-G expression in chronic lymphocytic leukemia Section: Neoplasia

    Holger Nuckel;Vera Rebmann;Jan Durig;Ulrich Duhrsen

Frequent Co-Authors

Hans Grosse-Wilde
Hans Grosse-Wilde University of Duisburg-Essen
Bernd Giebel
Bernd Giebel University of Duisburg-Essen
Edgardo D. Carosella
Edgardo D. Carosella Université Paris Cité
Joel LeMaoult
Joel LeMaoult Université Paris Cité
Ulrich Dührsen
Ulrich Dührsen University of Duisburg-Essen
Ilias I.N. Doxiadis
Ilias I.N. Doxiadis Leiden University Medical Center
Frans H.J. Claas
Frans H.J. Claas Leiden University Medical Center
Soldano Ferrone
Soldano Ferrone Harvard University
Dirk M. Hermann
Dirk M. Hermann University of Duisburg-Essen
Johannes H. Schulte
Johannes H. Schulte Charité - University Medicine Berlin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens doors to various healthcare and research careers. Many students pursue nursing pathways to apply immunological knowledge in clinical settings. For those aiming to advance their practice, exploring an acute care nurse practitioner certification can enhance specialization and patient care skills.

If you're considering faster routes to becoming a nurse practitioner, numerous accelerated FNP programs offer quality training online, allowing students to balance education with other commitments. For individuals without a nursing background, online ABSN programs for non nurses provide a flexible option to enter the nursing field, even if you already hold a degree in another area.

Additionally, those looking for entry points into nursing education can consider the easiest ABSN programs to get into, which often have more accessible admissions requirements while maintaining strong curriculum standards. Such programs can be an excellent start for immunology enthusiasts seeking a practical healthcare role.

Best Scientists Citing Vera Rebmann

Trending Scientists

Recently Published Articles